Medicare Enrolled

Dr. Dheeraj Reddy, M.D

Hematology & Oncology · Garland, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
7150 N PRESIDENT GEORGE BUSH HWY STE 200, Garland, TX 75044
9722723417
In practice since 2010 (15 years)
NPI: 1871804757 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reddy

Dr. Dheeraj Reddy is a hematology & oncology in Garland, TX, with 15 years in practice. Based on federal Medicare data, Dr. Reddy performed 78,943 Medicare services across 2,153 unique beneficiaries.

Between the years covered by Open Payments, Dr. Reddy received a total of $4,738 from 40 pharmaceutical and/or device companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ Top 12% volume in TX$ $4,738 industry payments

Medicare Practice Summary

Medicare Utilization ↗
78,943
Medicare services
Top 12% in TX for hematology & oncology
2,153
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,263 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)31,620$0$5
Iron sucrose injection (Venofer)26,000$0$2
Darbepoetin injection (Aranesp) for anemia12,525$2$20
Denosumab injection (Prolia/Xgeva)1,380$19$67
Dexamethasone injection (steroid)1,358$0$1
Blood draw (venipuncture)691$8$20
Complete blood count (CBC) with differential680$8$36
Anti-nausea injection (Aloxi/palonosetron)590$1$114
Comprehensive metabolic blood panel499$10$64
Office visit, established patient (30-39 min)431$95$368
Injection, granisetron hydrochloride, 100 mcg430$0$24
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less265$49$313
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less202$22$157
Iron level test176$6$27
Iron binding capacity test176$9$35
Ferritin level test (iron stores)175$13$60
Office visit, established patient, complex (40-54 min)172$136$496
Drug injection, under skin or into muscle169$11$96
Administration of chemotherapy into vein, 1 hour or less163$101$707
Injection, zoledronic acid, 1 mg136$6$431
Lactate dehydrogenase (enzyme) level117$6$31
Injection of additional new drug or substance into vein83$12$108
Infusion, normal saline solution , 1000 cc73$2$19
Measurement of immunoglobulin light chains72$17$60
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-372$20$128
Complete blood count (CBC), automated67$6$34
Injection, diphenhydramine hcl, up to 50 mg66$1$7
Administration of additional new drug or substance into vein, 1 hour or less59$49$344
Administration of chemotherapy into vein, each additional hour53$22$161
New patient office visit (45-59 min)53$124$565
Irrigation of implanted venous access drug delivery device43$18$114
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour40$16$100
Microscopic examination for white blood cells with manual cell count36$4$22
Hospital follow-up visit, high complexity35$91$357
Reticulated (young) platelet measurement33$35$143
Infusion into a vein for hydration, 31-60 minutes32$25$256
Infusion into a vein for hydration, each additional hour32$10$75
Initial hospital admission, high complexity28$133$694
Red blood count automated, with additional calculations24$5$26
Carcinoembryonic antigen (cea) protein level22$19$99
Injection of drug or substance into vein20$28$247
Hospital follow-up visit, moderate complexity17$61$247
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries15$90$657
New patient office visit, complex (60-74 min)13$158$709
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
40.9% high complexity
54.4% medium
4.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,738
Total received (2021-2024)
Avg $1,185/year across 4 years
Top 44% in TX for hematology & oncology
40
Companies
165
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,809 (80.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$748 (15.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$181 (3.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,067
2023
$1,643
2022
$15
2021
$12

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,083
SOBI, INC
$359
Tempus AI, Inc
$271
Gilead Sciences, Inc.
$241
Daiichi Sankyo Inc.
$229
Astellas Pharma US Inc
$201
PharmaEssentia USA Corporation
$200
E.R. Squibb & Sons, L.L.C.
$185
Novartis Pharmaceuticals Corporation
$167
PFIZER INC.
$165
Genentech USA, Inc.
$155
Merck Sharp & Dohme LLC
$153
Bayer Healthcare Pharmaceuticals Inc.
$140
SHIELD THERAPEUTICS INC
$126
Incyte Corporation
$90
ABBVIE INC.
$89
GlaxoSmithKline, LLC.
$85
Janssen Biotech, Inc.
$68
Sirtex Medical Inc
$68
Aveo Pharmaceuticals, Inc.
$55
Jazz Pharmaceuticals Inc.
$54
ARRAY BIOPHARMA INC
$54
Karyopharm Therapeutics Inc.
$50
Rigel Pharmaceuticals, Inc.
$45
CTI BioPharma Corp.
$39
MorphoSys, US Inc.
$39
Eisai Inc.
$33
JAZZ PHARMACEUTICALS INC.
$33
Takeda Pharmaceuticals U.S.A., Inc.
$32
BeiGene USA, Inc.
$29
Regeneron Healthcare Solutions, Inc.
$27
Lilly USA, LLC
$24
Mirati Therapeutics, Inc.
$23
Kyowa Kirin, Inc.
$23
Dendreon Pharmaceuticals LLC
$21
Stemline Therapeutics Inc.
$20
NESTLE HEALTHCARE NUTRITION INC.
$20
Genmab U.S., Inc.
$16
Amgen Inc.
$14
Seagen Inc.
$13
Top 3 companies account for 36.1% of total payments
Associated products mentioned in payments ›
ACCRUFER · Alecensa · BESREMI · BOSULIF · BRUKINSA · CALQUENCE · DOPTELET · Doptelet · ELIQUIS · ENHERTU · EPKINLY · ERLEADA · Enhertu · Epkinly · FOTIVDA · Fabhalta · IBRANCE · ICLUSIG · IMFINZI · INLYTA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · Nubeqa · OJJAARA · OPDIVO · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Polivy · Poteligeo · RYBREVANT · Rezlidhia · SIR-Spheres Microspheres · Stivarga · TABRECTA · Tecentriq · Tecentriq Hybreza · Trodelvy · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · XALKORI · XPOVIO · XT CDX · Xtandi · ZEJULA · ZENPEP · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $6 per 100 Medicare services performed
Looking for a hematology & oncology in Garland?
Compare hematology & oncologys in the Garland area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
122
Per 100K population
4.7
County median income
$74,149
Nearest hospital
METHODIST RICHARDSON MEDICAL CENTER
2.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Reddy is a mixed practice specialist, with above-average Medicare volume (top 12% in TX), and low-engagement industry engagement, with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Reddy experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Reddy performed 31,620 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $4,738 from 40 companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other hematology & oncologys in Garland?
Dr. Reddy's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →